Corrigendum to “MK2206 enhances cisplatin-induced cytotoxicity and apoptosis in testicular cancer through Akt signaling pathway inhibition” [Transl Oncol. 2020 Jul;13(7):100769]

The authors regret the Ki-67 immunostaining of MK2206 group (the third image) in Figure 5B was misapplied in the originally published version of this article [1]. It has been corrected and modified as follows. This correction does not affect results and scientific conclusions of the research.

Fig. 5.

(B) Histological examination of the effect of CDDP and MK2206 on a P19 tumor in vivo. At day 15, the mice were sacrificed and the tumors were dissected. The expression of Ki-67 was assessed by immunohistochemistry. The percentage of Ki-67-positive cells in each treatment group was compared (*P<0.05 vs. control; **P<0.05, CDDP+MK2206 vs. CDDP; CDDP+ MK2206 vs. MK2206).

The authors would like to apologize for any inconvenience caused.